Delivery Order SPE2DB22D1103-SPE2DB25FH2N1
Award Date 9/17/25
Potential Completion Date 9/18/25
Potential Value $24K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,311.62 on September 15, 2025, for Otezla 20 mg tablets (60-count supply). This is a firm fixed-price, non-competitive delivery order with an ultimate completion date of September 16, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Otezla is a prescription medication used primarily to treat psoriasis, psoriatic arthritis, and behçet's disease. This...
- The Defense Logistics Agency awarded a delivery order valued at $16,471.83 to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Otezla 30 mg tablets (60-count units). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by June 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Otezla is a pharmaceutical treatment commonly used for psoriasis, psoriatic arthritis,...
- The Defense Logistics Agency awarded a delivery order valued at $16,991.63 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of September 15, 2025. The delivery order was issued on September 12, 2025, with performance to take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order valued at $17,101.64 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count packages) on August 22, 2025, with an ultimate completion date of August 25, 2025. The contract utilizes firm fixed price pricing with no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Otezla 30 mg tablets (60-count units) at a ceiling value of $4,477.65. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procedures. The contract is set to complete by May 21, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Otezla is a prescription medication used to treat...
- The Defense Logistics Agency awarded a delivery order valued at $4,576.65 to AmerisourceBergen Drug Corp for Otezla 30 mg tablets (60-count supply) on July 24, 2025, with a completion date of July 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Otezla is a prescription immunosuppressant medication used to treat various inflammatory...
- The Defense Logistics Agency awarded a delivery order valued at $62,896.54 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on July 24, 2025, with completion scheduled for July 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Otezla is a prescription medication used to treat psoriasis, psoriatic arthritis, and ankylosing...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Otezla 30 mg tablets (60-count) with a ceiling value of $48,019.25. This firm fixed-price delivery order represents a non-set-aside competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $10,400.01 to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg, a pharmaceutical product commonly used in the treatment of autoimmune conditions. The contract was executed on August 12, 2025, with an ultimate completion date of August 13, 2025, and utilizes firm fixed price pricing. The award represents a competitive, non-set-aside procurement processed through AmerisourceBergen's existing contract vehicle with DLA. The...
- The Defense Logistics Agency awarded a $21,010.71 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Otezla 30 mg tablets (60-count). This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal...